Literature DB >> 31996433

Polymorphisms in Human Cytomegalovirus Glycoprotein O (gO) Exert Epistatic Influences on Cell-Free and Cell-to-Cell Spread and Antibody Neutralization on gH Epitopes.

Le Zhang Day1,2, Cora Stegmann3,2, Eric P Schultz3,4,2, Jean-Marc Lanchy3,2, Qin Yu3,2, Brent J Ryckman5,4,1,2.   

Abstract

Human cytomegalovirus (HCMV) glycoproteins H and L (gH/gL) can be bound by either gO or the UL128 to UL131 proteins (referred to here as UL128-131) to form complexes that facilitate entry and spread, and the complexes formed are important targets of neutralizing antibodies. Strains of HCMV vary considerably in the levels of gH/gL/gO and gH/gL/UL128-131, and this can impact infectivity and cell tropism. In this study, we investigated how natural interstrain variation in the amino acid sequence of gO influences the biology of HCMV. Heterologous gO recombinants were constructed in which 6 of the 8 alleles or genotypes (GT) of gO were analyzed in the backgrounds of strains TR and Merlin (ME). The levels of gH/gL complexes were not affected, but there were impacts on entry, spread, and neutralization by anti-gH antibodies. AD169 (AD) gO (GT1a) [referred to here as ADgO(GT1a)] drastically reduced cell-free infectivity of both strains on fibroblasts and epithelial cells. PHgO(GT2a) increased cell-free infectivity of TR in both cell types, but spread in fibroblasts was impaired. In contrast, spread of ME in both cell types was enhanced by Towne (TN) gO (GT4), despite similar cell-free infectivity. TR expressing TNgO(GT4) was resistant to neutralization by anti-gH antibodies AP86 and 14-4b, whereas ADgO(GT1a) conferred resistance to 14-4b but enhanced neutralization by AP86. Conversely, ME expressing ADgO(GT1a) was more resistant to 14-4b. These results suggest that (i) there are mechanistically distinct roles for gH/gL/gO in cell-free and cell-to-cell spread, (ii) gO isoforms can differentially shield the virus from neutralizing antibodies, and (iii) effects of gO polymorphisms are epistatically dependent on other variable loci.IMPORTANCE Advances in HCMV population genetics have greatly outpaced understanding of the links between genetic diversity and phenotypic variation. Moreover, recombination between genotypes may shuffle variable loci into various combinations with unknown outcomes. UL74(gO) is an important determinant of HCMV infectivity and one of the most diverse loci in the viral genome. By analyzing interstrain heterologous UL74(gO) recombinants, we showed that gO diversity can have dramatic impacts on cell-free and cell-to-cell spread as well as on antibody neutralization and that the manifestation of these impacts can be subject to epistatic influences of the global genetic background. These results highlight the potential limitations of laboratory studies of HCMV biology that use single, isolated genotypes or strains.
Copyright © 2020 American Society for Microbiology.

Entities:  

Keywords:  antibody neutralization; cytomegalovirus; entry; epistasis; genetic diversity; glycoproteins; spread; tropism

Year:  2020        PMID: 31996433      PMCID: PMC7108825          DOI: 10.1128/JVI.02051-19

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  66 in total

1.  UL74 of human cytomegalovirus reduces the inhibitory effect of gH-specific and gB-specific antibodies.

Authors:  Xiao Jing Jiang; Kerstin Laib Sampaio; Nicole Ettischer; York-Dieter Stierhof; Gerhard Jahn; Barbara Kropff; Michael Mach; Christian Sinzger
Journal:  Arch Virol       Date:  2011-09-22       Impact factor: 2.574

2.  The genes encoding the gCIII complex of human cytomegalovirus exist in highly diverse combinations in clinical isolates.

Authors:  Lucy Rasmussen; Aimee Geissler; Catherine Cowan; Amanda Chase; Mark Winters
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

3.  Antibodies against the gH/gL/UL128/UL130/UL131 complex comprise the majority of the anti-cytomegalovirus (anti-CMV) neutralizing antibody response in CMV hyperimmune globulin.

Authors:  Ashley E Fouts; Pamela Chan; Jean-Philippe Stephan; Richard Vandlen; Becket Feierbach
Journal:  J Virol       Date:  2012-04-24       Impact factor: 5.103

4.  The Human Cytomegalovirus Trimer and Pentamer Promote Sequential Steps in Entry into Epithelial and Endothelial Cells at Cell Surfaces and Endosomes.

Authors:  Jing Liu; Ted S Jardetzky; Andrea L Chin; David C Johnson; Adam L Vanarsdall
Journal:  J Virol       Date:  2018-10-12       Impact factor: 5.103

5.  An Unbiased Screen for Human Cytomegalovirus Identifies Neuropilin-2 as a Central Viral Receptor.

Authors:  Nadia Martinez-Martin; Jessica Marcandalli; Christine S Huang; Christopher P Arthur; Michela Perotti; Mathilde Foglierini; Hoangdung Ho; Annie M Dosey; Stephanie Shriver; Jian Payandeh; Alexander Leitner; Antonio Lanzavecchia; Laurent Perez; Claudio Ciferri
Journal:  Cell       Date:  2018-07-26       Impact factor: 41.582

6.  Identification of the major capsid protein gene of human cytomegalovirus.

Authors:  M Chee; S A Rudolph; B Plachter; B Barrell; G Jahn
Journal:  J Virol       Date:  1989-03       Impact factor: 5.103

Review 7.  Fusing structure and function: a structural view of the herpesvirus entry machinery.

Authors:  Sarah A Connolly; Julia O Jackson; Theodore S Jardetzky; Richard Longnecker
Journal:  Nat Rev Microbiol       Date:  2011-04-11       Impact factor: 60.633

8.  Scanning Mutagenesis of Human Cytomegalovirus Glycoprotein gH/gL.

Authors:  Eric P Schultz; Jean-Marc Lanchy; Erin E Ellerbeck; Brent J Ryckman
Journal:  J Virol       Date:  2015-12-09       Impact factor: 5.103

9.  The pentameric complex drives immunologically covert cell-cell transmission of wild-type human cytomegalovirus.

Authors:  Isa Murrell; Carmen Bedford; Kristin Ladell; Kelly L Miners; David A Price; Peter Tomasec; Gavin W G Wilkinson; Richard J Stanton
Journal:  Proc Natl Acad Sci U S A       Date:  2017-05-22       Impact factor: 12.779

10.  Genetic Stability of Bacterial Artificial Chromosome-Derived Human Cytomegalovirus during Culture In Vitro.

Authors:  Isa Murrell; Gavin S Wilkie; Andrew J Davison; Evelina Statkute; Ceri A Fielding; Peter Tomasec; Gavin W G Wilkinson; Richard J Stanton
Journal:  J Virol       Date:  2016-03-28       Impact factor: 6.549

View more
  11 in total

1.  Specialization for Cell-Free or Cell-to-Cell Spread of BAC-Cloned Human Cytomegalovirus Strains Is Determined by Factors beyond the UL128-131 and RL13 Loci.

Authors:  Eric P Schultz; Jean-Marc Lanchy; Le Zhang Day; Qin Yu; Christopher Peterson; Jessica Preece; Brent J Ryckman
Journal:  J Virol       Date:  2020-06-16       Impact factor: 5.103

2.  Cross Strain Protection against Cytomegalovirus Reduces DISC Vaccine Efficacy against CMV in the Guinea Pig Model.

Authors:  K Yeon Choi; Nadia S El-Hamdi; Alistair McGregor
Journal:  Viruses       Date:  2022-04-06       Impact factor: 5.818

3.  Convalescent Immunity to Guinea Pig Cytomegalovirus Induces Limited Cross Strain Protection against Re-Infection but High-Level Protection against Congenital Disease.

Authors:  K Yeon Choi; Nadia S El-Hamdi; Alistair McGregor
Journal:  Int J Mol Sci       Date:  2020-08-20       Impact factor: 5.923

4.  Targeted mutagenesis on PDGFRα-Fc identifies amino acid modifications that allow efficient inhibition of HCMV infection while abolishing PDGF sequestration.

Authors:  Svenja Feldmann; Immanuel Grimm; Dagmar Stöhr; Chiara Antonini; Peter Lischka; Christian Sinzger; Cora Stegmann
Journal:  PLoS Pathog       Date:  2021-03-29       Impact factor: 6.823

5.  Cryo-Electron Microscopy Structure and Interactions of the Human Cytomegalovirus gHgLgO Trimer with Platelet-Derived Growth Factor Receptor Alpha.

Authors:  Jing Liu; Adam Vanarsdall; Dong-Hua Chen; Andrea Chin; David Johnson; Theodore S Jardetzky
Journal:  mBio       Date:  2021-10-26       Impact factor: 7.867

Review 6.  Well Put Together-A Guide to Accessorizing with the Herpesvirus gH/gL Complexes.

Authors:  Gonzalo L Gonzalez-Del Pino; Ekaterina E Heldwein
Journal:  Viruses       Date:  2022-01-30       Impact factor: 5.818

7.  Development of broadly neutralizing antibodies targeting the cytomegalovirus subdominant antigen gH.

Authors:  Andrea J Parsons; Sabrina I Ophir; J Andrew Duty; Thomas A Kraus; Kathryn R Stein; Thomas M Moran; Domenico Tortorella
Journal:  Commun Biol       Date:  2022-04-25

8.  Intermittent bulk release of human cytomegalovirus.

Authors:  Felix J Flomm; Timothy K Soh; Carola Schneider; Linda Wedemann; Hannah M Britt; Konstantinos Thalassinos; Søren Pfitzner; Rudolph Reimer; Kay Grünewald; Jens B Bosse
Journal:  PLoS Pathog       Date:  2022-08-04       Impact factor: 7.464

9.  Mutagenesis of Human Cytomegalovirus Glycoprotein L Disproportionately Disrupts gH/gL/gO over gH/gL/pUL128-131.

Authors:  Eric P Schultz; Qin Yu; Cora Stegmann; Le Zhang Day; Jean-Marc Lanchy; Brent J Ryckman
Journal:  J Virol       Date:  2021-08-10       Impact factor: 5.103

Review 10.  Common Polymorphisms in the Glycoproteins of Human Cytomegalovirus and Associated Strain-Specific Immunity.

Authors:  Hsuan-Yuan Wang; Sarah M Valencia; Susanne P Pfeifer; Jeffrey D Jensen; Timothy F Kowalik; Sallie R Permar
Journal:  Viruses       Date:  2021-06-09       Impact factor: 5.818

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.